Cargando…

Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine

Intranasal immunization with whole inactivated virus (WIV) is an important strategy used for influenza prevention and control. However, a powerful mucosal adjuvant is required to improve nasal vaccine efficacy. Riboflavin, as a food additive with the advantages of being safe and low-cost, widely exi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yinyan, Wang, Jinyuan, Xu, Xing, Zhou, Bangyue, Chen, Sujuan, Qin, Tao, Peng, Daxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617635/ https://www.ncbi.nlm.nih.gov/pubmed/34835227 http://dx.doi.org/10.3390/vaccines9111296

Ejemplares similares

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
por: Qin, Tao, et al.
Publicado: (2020)

PA-X protein of H1N1 subtype influenza virus disables the nasal mucosal dendritic cells for strengthening virulence
por: Qin, Tao, et al.
Publicado: (2022)

Generation of an avian influenza DIVA vaccine with a H3-peptide replacement located at HA2 against both highly and low pathogenic H7N9 virus
por: Li, Gang, et al.
Publicado: (2022)

Bidirectionally Regulating Viral and Cellular Ferroptosis with Metastable Iron Sulfide Against Influenza Virus
por: Miao, Xinyu, et al.
Publicado: (2023)

PA-X protein of H9N2 subtype avian influenza virus suppresses the innate immunity of chicken bone marrow-derived dendritic cells
por: Qin, Tao, et al.
Publicado: (2022)

Melatonin Suppresses LPS-Induced Oxidative Stress in Dendritic Cells for Inflammatory Regulation via the Nrf2/HO-1 Axis
por: Qin, Tao, et al.
Publicado: (2022)

Catalytic inactivation of influenza virus by iron oxide nanozyme
por: Qin, Tao, et al.
Publicado: (2019)

The Respiratory Commensal Bacterium Corynebacterium pseudodiphtheriticum as a Mucosal Adjuvant for Nasal Vaccines
por: Ortiz Moyano, Ramiro, et al.
Publicado: (2023)

Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses
por: Chen, Sujuan, et al.
Publicado: (2017)

Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination
por: Falkeborn, Tina, et al.
Publicado: (2013)

Characterization of an H7N9 Influenza Virus Isolated from Camels in Inner Mongolia, China
por: Yin, Yuncong, et al.
Publicado: (2023)

Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
por: Sun, Zhihao, et al.
Publicado: (2021)

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
por: Anggraeni, Rahmi, et al.
Publicado: (2022)

Mucosal vaccine adjuvants update
por: Rhee, Joon Haeng, et al.
Publicado: (2012)

Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in mice
por: Xu, Jing, et al.
Publicado: (2018)

Astaxanthin Provides Antioxidant Protection in LPS-Induced Dendritic Cells for Inflammatory Control
por: Yin, Yinyan, et al.
Publicado: (2021)

Development of a multiplex probe combination-based one-step real-time reverse transcription-PCR for NA subtype typing of avian influenza virus
por: Sun, Zhihao, et al.
Publicado: (2017)

Glycosylation at 11Asn on hemagglutinin of H5N1 influenza virus contributes to its biological characteristics
por: Yin, Yuncong, et al.
Publicado: (2017)

Truncation or Deglycosylation of the Neuraminidase Stalk Enhances the Pathogenicity of the H5N1 Subtype Avian Influenza Virus in Mallard Ducks
por: Chen, Sujuan, et al.
Publicado: (2020)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Emerging of H5N6 Subtype Influenza Virus with 129-Glycosylation Site on Hemagglutinin in Poultry in China Acquires Immune Pressure Adaption
por: Xu, Nuo, et al.
Publicado: (2022)

Identification of a universal antigen epitope of influenza A virus using peptide microarray
por: Wang, Qiuxia, et al.
Publicado: (2021)

A Live Attenuated H9N2 Avian Influenza Vaccine Prevents the Viral Reassortment by Exchanging the HA and NS1 Packaging Signals
por: Chen, Sujuan, et al.
Publicado: (2021)

Modes of Action for Mucosal Vaccine Adjuvants
por: Aoshi, Taiki
Publicado: (2017)

Influenza a virus antagonizes type I and type II interferon responses via SOCS1-dependent ubiquitination and degradation of JAK1
por: Du, Yinping, et al.
Publicado: (2020)

Potentials of saponins-based adjuvants for nasal vaccines
por: Chen, Kai, et al.
Publicado: (2023)

How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions
por: Gianchecchi, Elena, et al.
Publicado: (2019)

Molecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccination
por: Pannaraj, Pia S., et al.
Publicado: (2022)

Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines
por: Savelkoul, Huub F. J., et al.
Publicado: (2015)

Microbiota Influences Vaccine and Mucosal Adjuvant Efficacy
por: Kim, Yun-Gi
Publicado: (2017)

Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice
por: Fukuyama, Yoshiko, et al.
Publicado: (2015)

Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity
por: Liu, Jun, et al.
Publicado: (2023)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

Cholesteryl Pullulan Encapsulated TNF-α Nanoparticles Are an Effective Mucosal Vaccine Adjuvant against Influenza Virus
por: Nagatomo, Daiki, et al.
Publicado: (2015)

Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of H7N9 Influenza Viruses
por: Sun, Zhihao, et al.
Publicado: (2018)

Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice
por: Hinkula, Jorma, et al.
Publicado: (2019)

Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice
por: Cao, Weiping, et al.
Publicado: (2017)

Synergistic effect of PB2 283M and 526R contributes to enhanced virulence of H5N8 influenza viruses in mice
por: Wang, Xiao, et al.
Publicado: (2017)

The synergistic effect of residues 32T and 550L in the PA protein of H5 subtype avian influenza virus contributes to viral pathogenicity in mice
por: Yang, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rq04nv7u3af1r8bo63nlp713v4